Jennifer Whitney04.18.08
Boston Scientific will purchase CryoCor for approximately $17.6 million. The acquisition follows a June 2007 development agreement to pursue therapeutic solutions for atrial fibrillation.
The agreement involves the development of a console to deliver cryo energy to Boston Scientifics proprietary cryo balloon catheter, Boston Scientific said.
The merger is expected to close this quarter.
SOURCE: FDAnews